beatandraise : SEC Filings Research with AI

beatandraise

beta

Merck & Co., Inc.

Something amiss? let us know.

[email protected]

Source Link

beatandraise.com

beatandraise.com

beta

Merck & Co., Inc.

Exhibits

y77207a2sv4za.htm y77207a2exv3w1wb.htm y77207a2exv5w1.htm y77207a2exv8w1.htm y77207a2exv8w2.htm y77207a2exv15w1.htm y77207a2exv23w1.htm y77207a2exv23w2.htm y77207a2exv23w3.htm y77207a2exv99w1.htm y77207a2exv99w2.htm y77207a2exv99w6.htm y77207a2exv99w7.htm y77207a2exv99w9.htm y77207a2exv99w10.htm y77207a2exv99w11.htm y77207a2exv99w12.htm y77207a2exv99w13.htm y77207a2exv99w14.htm y77207a2exv99w15.htm y77207a2exv99w16.htm y77207a2exv99w17.htm y77207a2exv99w18.htm y77207a2exv99w19.htm y77207a2exv99w20.htm y77207a2exv99w21.htm y77207a2exv99w22.htm y77207a2exv99w23.htm

beatandraise.com

beta

Merck & Co., Inc.

Exhibits

y77207a2sv4za.htm y77207a2exv3w1wb.htm y77207a2exv5w1.htm y77207a2exv8w1.htm y77207a2exv8w2.htm y77207a2exv15w1.htm y77207a2exv23w1.htm y77207a2exv23w2.htm y77207a2exv23w3.htm y77207a2exv99w1.htm y77207a2exv99w2.htm y77207a2exv99w6.htm y77207a2exv99w7.htm y77207a2exv99w9.htm y77207a2exv99w10.htm y77207a2exv99w11.htm y77207a2exv99w12.htm y77207a2exv99w13.htm y77207a2exv99w14.htm y77207a2exv99w15.htm y77207a2exv99w16.htm y77207a2exv99w17.htm y77207a2exv99w18.htm y77207a2exv99w19.htm y77207a2exv99w20.htm y77207a2exv99w21.htm y77207a2exv99w22.htm y77207a2exv99w23.htm

EX-99.16

Exhibit 99.16

CONSENT OF PERSON ABOUT TO BECOME A DIRECTOR

Pursuant to Rule 438 promulgated under the Securities Act of 1933, as amended, the undersigned hereby consents to be named as a person about to become a director of Schering-Plough Corporation (to be renamed Merck & Co., Inc.) in the Registration Statement on Form S-4 filed by Schering-Plough Corporation with the Securities and Exchange Commission (File No. 333-159371) under the Securities Act of 1933, as amended.



	/s/ William N. Kelley, M.D.
	Name:	William N. Kelley, M.D.

June 12, 2009